BioRestorative Therapies Announces $5 Million Public Offering to Fund Operations

BioRestorative Therapies, Inc. has announced the pricing of a public offering valued at $5.0 million. The company disclosed this information on February 12, 2026, outlining the terms and structure of the offering aimed at raising capital for its operations.

According to the announcement, the offering consists of units priced at $X per unit, with each unit comprising one share of common stock and accompanying warrants. The warrants will allow holders to purchase additional shares at a specified price within a defined time frame. BioRestorative stated that it intends to use the proceeds from this offering for general corporate purposes, including research and development activities, working capital needs, and other operational expenses. Further details regarding the closing date and distribution process were not included in the initial release but are expected to follow in subsequent updates.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 12, 2026

Author

GOAI